Table 2. Baseline characteristics of pooled study populations.
Parameter | Control (n=1053) | Epoetin-β (n=1244) |
---|---|---|
Gender (Percentage of male/female) | 37/63 | 38/62 |
Race | ||
n | 921 | 1069 |
Caucasian | 882 (96%) | 1029 (96%) |
Other | 39 (4%) | 40 (4%) |
Mean age in years (range) | 58.8 (19–91) | 59.3 (20–87) |
Mean weight in kg (range) | 67.7 (30.0–131.5) | 67.1 (35.0–118.0) |
n | 1048 | 1235 |
Mean height in cm (range) | 166.7 (140–198) | 166.4 (126–198) |
n | 809 | 1012 |
Tumour type, n (%) | ||
Haematological | 331 (31.4) | 465 (37.4) |
Acute myeloid leukaemia | 10 (3.0) | 10 (2.2) |
Multiple myeloma | 125 (37.8) | 204 (43.9) |
Non-Hodgkin's lymphoma | 195 (58.9) | 247 (53.1) |
Hodgkin's lymphoma | 1 (<1) | 4 (<1) |
Solid | 722 (68.6) | 779 (62.6) |
Breast | 261 (36.2) | 261 (33.5) |
Head/neck | 174 (24.1) | 181 (23.2) |
Gynaecological | 133 (18.4) | 186 (23.9) |
Gastrointestinal | 96 (13.3) | 100 (12.8) |
Other | 58 (8.0) | 51 (6.6) |
Haemoglobin | ||
n | 1050 | 1241 |
Mean (range) | 10.6 (5.7–16.7) | 10.5 (4.2–17.1) |
Median | 10.5 | 10.4 |
Data were collected from all 2297 patients unless otherwise stated.
Reproduced from Aapro et al, 2008a.